The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Will The Market Value Of The Precision Genomic Testing Market Change Between 2026 And 2030?
The precision genomic testing market has experienced rapid expansion over recent years. It is projected to grow from $15 billion in 2025 to $16.75 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. The growth observed in the historic period can be attributed to advancements in sequencing technologies, expansion of precision oncology programs, increasing availability of genomic databases, growth in clinical research funding, and rising awareness of genetic disorders.
The precision genomic testing market is projected for substantial expansion over the next few years. By 2030, its valuation is anticipated to reach $25.71 billion, demonstrating a compound annual growth rate (CAGR) of 11.3%. This expansion during the projection period stems from factors such as the greater acceptance of precision medicine, increased funding in genomic research, the proliferation of population-level genomic programs, the escalating need for companion diagnostics, and the deeper integration of genomics into standard clinical procedures. Key developments anticipated within this timeframe involve the wider uptake of next-generation sequencing, the growing application of AI for genomic interpretation, an increasing need for customized treatment strategies, the broadening scope of clinical genomic testing, and improved integration of bioinformatics platforms.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25883&type=smp
What Core Drivers Are Transforming The Precision Genomic Testing Market?
The increasing occurrence of genetic conditions is anticipated to drive expansion in the precision genomic testing market in the future. These disorders are defined as health issues stemming from irregularities in a person’s DNA, including single-gene mutations, multi-gene mutations, or alterations in chromosome structure or count. A key factor contributing to this rising prevalence is the advancing maternal age, given that older mothers face an elevated risk of transmitting chromosomal defects like Down syndrome to their offspring. Precision genomic testing facilitates the prompt discovery and precise identification of genetic disorders through the detection of particular genetic mutations, thereby enabling focused interventions and customized treatment plans. For example, in May 2025, Gene People, a registered charity operating in the UK, reported that approximately 1 in 25 children are affected by genetic conditions, influencing more than 2.4 million children and adults across the UK. Furthermore, about 30,000 infants and children in the UK receive a genetic condition diagnosis annually. Consequently, the increased occurrence of genetic disorders is fueling the expansion of the precision genomic testing market.
How Is The Precision Genomic Testing Market Examined Through Segment Analysis?
The precision genomic testing market covered in this report is segmented –
1) By Product And Service: Consumables, Equipment, Services
2) By Technology: Next-Generation Sequencing, Polymerase Chain Reaction, Microarray Technology, Sanger Sequencing, Clustered Regularly Interspaced Short Palindromic Repeats Or Clustered Regularly Interspaced Short Palindromic Repeats-Associated Systems, Other Technologies
3) By Application: Oncology, Cardiovascular Diseases, Neurological Disorders, Reproductive Health, Rare Diseases, Other Applications
4) By End-Users: Hospitals And Clinics, Diagnostic Laboratories, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Consumables: Reagents And Kits, Deoxyribonucleic Acid Or Ribonucleic Acid Extraction Kits, Library Preparation Kits, Sequencing Reagents, Polymerase Chain Reaction Assay Kits, Buffers And Enzymes
2) By Equipment: Next-Generation Sequencing Systems, Polymerase Chain Reaction Machines, Microarray Instruments, Deoxyribonucleic Acid Analyzers, Bioinformatics Workstations, Laboratory Automation Systems
3) By Services: Genomic Data Analysis Services, Laboratory Testing Services, Genetic Counseling Services, Clinical Interpretation Services, Contract Research Services, Custom Assay Development Services
Which Trends Are Expected To Shape The Precision Genomic Testing Market?
Leading companies within the precision diagnostics market are increasingly concentrating on innovative therapeutic strategies. This involves the introduction of AI-powered video analysis tools, which aim to enhance patient engagement and clarify complex medical data, ultimately empowering individuals to manage their own health. An AI-driven video analysis tool utilizes artificial intelligence to process video content, simplifying intricate information like health reports by emphasizing key parameters, thereby delivering clear insights for improved understanding and better-informed decision-making. For example, in August 2024, Healthians, an India-based diagnostic company, unveiled an industry-first AI-driven video analysis tool. This tool simplifies complex medical data by identifying crucial health parameters and explaining their importance, effectively guiding users through their health reports. This advanced feature allows users to receive personalized insights within 15-30 minutes after completing a concise questionnaire on the Healthians app, consequently strengthening their capability to make knowledgeable choices about their health.
Which Organizations Are Operating Within The Precision Genomic Testing Market?
Major companies operating in the precision genomic testing market are Roche Diagnostics International AG, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., Exact Sciences Corporation, Natera Inc., Myriad Genetics Inc., GenScript Biotech Corporation, Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., Ambry Genetics Corporation, Color Health Inc., Pacific Biosciences, Eurofins Genomics LLC, BGI Genomics Co. Ltd.
Access The Complete Precision Genomic Testing Market Report:
https://www.thebusinessresearchcompany.com/report/precision-genomic-testing-global-market-report
Which Region Stands As The Largest Contributor To The Precision Genomic Testing Market?
North America was the largest region in the precision genomic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision genomic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Precision Genomic Testing Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=25883&type=smp
Browse Through More Reports Similar to the Global Precision Genomic Testing Market 2026, By The Business Research Company
Precision Medicine Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report
Clinical Diagnostics Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/clinical-diagnostics-global-market-report
Precision Parts Global Market Report 2026
https://www.thebusinessresearchcompany.com/report/precision-parts-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model